Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil
Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were ident...
Gespeichert in:
| Veröffentlicht in: | Letters in applied microbiology 2018-09, Vol.67 (3), p.285-291 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 291 |
|---|---|
| container_issue | 3 |
| container_start_page | 285 |
| container_title | Letters in applied microbiology |
| container_volume | 67 |
| creator | Brandão, L.D.S. Boniek, D. Resende Stoianoff, M.A. Mata, F.M.R. Azevedo, P.R.M. Fernandes, J.V. Andrade, V.S. |
| description | Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were identified phenotypically as Candida albicans and one as Candida glabrata which is reported as the non‐albicans species most frequently isolated from vulvovaginitis. The susceptibility to selected antifungal agents (flucytosine, fluconazole, voriconazole, amphotericin B, caspofungin and micafungin) was determined, and the association between patient‐related signs and symptoms aided the construction of an epidemiological profile. Antifungal susceptibility testing performed by automated method showed that all strains were sensitive to the drugs tested, including the C. glabrata specimen despite its known resistance or dose‐dependent susceptibility to azole derivatives. Regarding patient signs and symptoms, no statistically significant association between these and the establishment of VVC was found. It can be concluded that the laboratorial diagnosis of VVC is necessary prior to the administration of treatment, since only 48·78% of the patients had VVC but for all of them antifungal therapy were prescribed.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic a |
| doi_str_mv | 10.1111/lam.13034 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2056394237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2084300154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3534-a964966994ae6069c4d2f10eb271b4370be581766cc4c0eed8ebc7de0d8642f63</originalsourceid><addsrcrecordid>eNp10U1rFDEYB_BQlHatPfQLlIAXBafN22Qmx7r4BtvqQcHbkMk8s6ZkkmmSsawHP7up23oQDIQc8sufJ_wROqXknJZ14fR0Tjnh4gCtqGhY1cj62xO0IkzKqmW1OELPUrohhLSUqUN0xJQiLeFshX59jvBDO_AGsPZD2dmOi99qh9OSDMzZ9tbZvMNhxOsi7KBxmsFYSFhPwW_xHGHryzt8FybwWOcMhZWLAs33EByedIbo70N0xtc6a_cav4n6p3XP0dNRuwQnD-cx-vru7Zf1h2rz6f3H9eWmMrzmotJKCiWlUkKDJFIZMbCREuhZQ3vBG9JD3dJGSmOEIQBDC71pBiBDKwUbJT9GL_e5cwy3C6TcTbb8zjntISypY6SWXAnGm0Jf_ENvwhJ9ma6oVnBCaC2KerVXJoaUIozdHO2k466jpLsvpSuldH9KKfbsIXHpJxj-yscWCrjYgzvrYPf_pG5zebWP_A1JDJbt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2084300154</pqid></control><display><type>article</type><title>Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Brandão, L.D.S. ; Boniek, D. ; Resende Stoianoff, M.A. ; Mata, F.M.R. ; Azevedo, P.R.M. ; Fernandes, J.V. ; Andrade, V.S.</creator><creatorcontrib>Brandão, L.D.S. ; Boniek, D. ; Resende Stoianoff, M.A. ; Mata, F.M.R. ; Azevedo, P.R.M. ; Fernandes, J.V. ; Andrade, V.S.</creatorcontrib><description>Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were identified phenotypically as Candida albicans and one as Candida glabrata which is reported as the non‐albicans species most frequently isolated from vulvovaginitis. The susceptibility to selected antifungal agents (flucytosine, fluconazole, voriconazole, amphotericin B, caspofungin and micafungin) was determined, and the association between patient‐related signs and symptoms aided the construction of an epidemiological profile. Antifungal susceptibility testing performed by automated method showed that all strains were sensitive to the drugs tested, including the C. glabrata specimen despite its known resistance or dose‐dependent susceptibility to azole derivatives. Regarding patient signs and symptoms, no statistically significant association between these and the establishment of VVC was found. It can be concluded that the laboratorial diagnosis of VVC is necessary prior to the administration of treatment, since only 48·78% of the patients had VVC but for all of them antifungal therapy were prescribed.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.</description><identifier>ISSN: 0266-8254</identifier><identifier>EISSN: 1472-765X</identifier><identifier>DOI: 10.1111/lam.13034</identifier><identifier>PMID: 29908032</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adolescent ; Adult ; Amphotericin B ; Amphotericin B - pharmacology ; Antifungal agents ; Antifungal Agents - pharmacology ; antifungal susceptibility ; Brazil - epidemiology ; Candida ; Candida - drug effects ; Candida - genetics ; Candida - isolation & purification ; Candida glabrata - isolation & purification ; Candida species ; Candidiasis ; Candidiasis, Vulvovaginal - epidemiology ; Candidiasis, Vulvovaginal - microbiology ; Caspofungin ; Diagnosis ; Echinocandins - pharmacology ; Epidemiology ; Female ; Fluconazole ; Fluconazole - pharmacology ; Flucytosine ; Fungi ; Fungicides ; Humans ; Infections ; Lipopeptides - pharmacology ; Micafungin ; Microbial Sensitivity Tests ; Patients ; Pregnancy ; Pregnancy Complications - epidemiology ; Pregnancy Complications - microbiology ; pregnant women ; Prevalence ; Schools - statistics & numerical data ; Signs and symptoms ; Species ; Statistical analysis ; Statistical methods ; Test procedures ; Vagina ; Voriconazole ; Vulva ; vulvovaginal candidiasis ; Vulvovaginitis ; Yeasts ; Young Adult</subject><ispartof>Letters in applied microbiology, 2018-09, Vol.67 (3), p.285-291</ispartof><rights>2018 The Society for Applied Microbiology</rights><rights>2018 The Society for Applied Microbiology.</rights><rights>Copyright © 2018 The Society for Applied Microbiology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3534-a964966994ae6069c4d2f10eb271b4370be581766cc4c0eed8ebc7de0d8642f63</citedby><cites>FETCH-LOGICAL-c3534-a964966994ae6069c4d2f10eb271b4370be581766cc4c0eed8ebc7de0d8642f63</cites><orcidid>0000-0001-6923-7143 ; 0000-0002-6220-1321</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Flam.13034$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Flam.13034$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29908032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brandão, L.D.S.</creatorcontrib><creatorcontrib>Boniek, D.</creatorcontrib><creatorcontrib>Resende Stoianoff, M.A.</creatorcontrib><creatorcontrib>Mata, F.M.R.</creatorcontrib><creatorcontrib>Azevedo, P.R.M.</creatorcontrib><creatorcontrib>Fernandes, J.V.</creatorcontrib><creatorcontrib>Andrade, V.S.</creatorcontrib><title>Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil</title><title>Letters in applied microbiology</title><addtitle>Lett Appl Microbiol</addtitle><description>Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were identified phenotypically as Candida albicans and one as Candida glabrata which is reported as the non‐albicans species most frequently isolated from vulvovaginitis. The susceptibility to selected antifungal agents (flucytosine, fluconazole, voriconazole, amphotericin B, caspofungin and micafungin) was determined, and the association between patient‐related signs and symptoms aided the construction of an epidemiological profile. Antifungal susceptibility testing performed by automated method showed that all strains were sensitive to the drugs tested, including the C. glabrata specimen despite its known resistance or dose‐dependent susceptibility to azole derivatives. Regarding patient signs and symptoms, no statistically significant association between these and the establishment of VVC was found. It can be concluded that the laboratorial diagnosis of VVC is necessary prior to the administration of treatment, since only 48·78% of the patients had VVC but for all of them antifungal therapy were prescribed.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Amphotericin B</subject><subject>Amphotericin B - pharmacology</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - pharmacology</subject><subject>antifungal susceptibility</subject><subject>Brazil - epidemiology</subject><subject>Candida</subject><subject>Candida - drug effects</subject><subject>Candida - genetics</subject><subject>Candida - isolation & purification</subject><subject>Candida glabrata - isolation & purification</subject><subject>Candida species</subject><subject>Candidiasis</subject><subject>Candidiasis, Vulvovaginal - epidemiology</subject><subject>Candidiasis, Vulvovaginal - microbiology</subject><subject>Caspofungin</subject><subject>Diagnosis</subject><subject>Echinocandins - pharmacology</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fluconazole</subject><subject>Fluconazole - pharmacology</subject><subject>Flucytosine</subject><subject>Fungi</subject><subject>Fungicides</subject><subject>Humans</subject><subject>Infections</subject><subject>Lipopeptides - pharmacology</subject><subject>Micafungin</subject><subject>Microbial Sensitivity Tests</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - epidemiology</subject><subject>Pregnancy Complications - microbiology</subject><subject>pregnant women</subject><subject>Prevalence</subject><subject>Schools - statistics & numerical data</subject><subject>Signs and symptoms</subject><subject>Species</subject><subject>Statistical analysis</subject><subject>Statistical methods</subject><subject>Test procedures</subject><subject>Vagina</subject><subject>Voriconazole</subject><subject>Vulva</subject><subject>vulvovaginal candidiasis</subject><subject>Vulvovaginitis</subject><subject>Yeasts</subject><subject>Young Adult</subject><issn>0266-8254</issn><issn>1472-765X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10U1rFDEYB_BQlHatPfQLlIAXBafN22Qmx7r4BtvqQcHbkMk8s6ZkkmmSsawHP7up23oQDIQc8sufJ_wROqXknJZ14fR0Tjnh4gCtqGhY1cj62xO0IkzKqmW1OELPUrohhLSUqUN0xJQiLeFshX59jvBDO_AGsPZD2dmOi99qh9OSDMzZ9tbZvMNhxOsi7KBxmsFYSFhPwW_xHGHryzt8FybwWOcMhZWLAs33EByedIbo70N0xtc6a_cav4n6p3XP0dNRuwQnD-cx-vru7Zf1h2rz6f3H9eWmMrzmotJKCiWlUkKDJFIZMbCREuhZQ3vBG9JD3dJGSmOEIQBDC71pBiBDKwUbJT9GL_e5cwy3C6TcTbb8zjntISypY6SWXAnGm0Jf_ENvwhJ9ma6oVnBCaC2KerVXJoaUIozdHO2k466jpLsvpSuldH9KKfbsIXHpJxj-yscWCrjYgzvrYPf_pG5zebWP_A1JDJbt</recordid><startdate>201809</startdate><enddate>201809</enddate><creator>Brandão, L.D.S.</creator><creator>Boniek, D.</creator><creator>Resende Stoianoff, M.A.</creator><creator>Mata, F.M.R.</creator><creator>Azevedo, P.R.M.</creator><creator>Fernandes, J.V.</creator><creator>Andrade, V.S.</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7ST</scope><scope>7T7</scope><scope>7TM</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>SOI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6923-7143</orcidid><orcidid>https://orcid.org/0000-0002-6220-1321</orcidid></search><sort><creationdate>201809</creationdate><title>Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil</title><author>Brandão, L.D.S. ; Boniek, D. ; Resende Stoianoff, M.A. ; Mata, F.M.R. ; Azevedo, P.R.M. ; Fernandes, J.V. ; Andrade, V.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3534-a964966994ae6069c4d2f10eb271b4370be581766cc4c0eed8ebc7de0d8642f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amphotericin B</topic><topic>Amphotericin B - pharmacology</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - pharmacology</topic><topic>antifungal susceptibility</topic><topic>Brazil - epidemiology</topic><topic>Candida</topic><topic>Candida - drug effects</topic><topic>Candida - genetics</topic><topic>Candida - isolation & purification</topic><topic>Candida glabrata - isolation & purification</topic><topic>Candida species</topic><topic>Candidiasis</topic><topic>Candidiasis, Vulvovaginal - epidemiology</topic><topic>Candidiasis, Vulvovaginal - microbiology</topic><topic>Caspofungin</topic><topic>Diagnosis</topic><topic>Echinocandins - pharmacology</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fluconazole</topic><topic>Fluconazole - pharmacology</topic><topic>Flucytosine</topic><topic>Fungi</topic><topic>Fungicides</topic><topic>Humans</topic><topic>Infections</topic><topic>Lipopeptides - pharmacology</topic><topic>Micafungin</topic><topic>Microbial Sensitivity Tests</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - epidemiology</topic><topic>Pregnancy Complications - microbiology</topic><topic>pregnant women</topic><topic>Prevalence</topic><topic>Schools - statistics & numerical data</topic><topic>Signs and symptoms</topic><topic>Species</topic><topic>Statistical analysis</topic><topic>Statistical methods</topic><topic>Test procedures</topic><topic>Vagina</topic><topic>Voriconazole</topic><topic>Vulva</topic><topic>vulvovaginal candidiasis</topic><topic>Vulvovaginitis</topic><topic>Yeasts</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brandão, L.D.S.</creatorcontrib><creatorcontrib>Boniek, D.</creatorcontrib><creatorcontrib>Resende Stoianoff, M.A.</creatorcontrib><creatorcontrib>Mata, F.M.R.</creatorcontrib><creatorcontrib>Azevedo, P.R.M.</creatorcontrib><creatorcontrib>Fernandes, J.V.</creatorcontrib><creatorcontrib>Andrade, V.S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Letters in applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brandão, L.D.S.</au><au>Boniek, D.</au><au>Resende Stoianoff, M.A.</au><au>Mata, F.M.R.</au><au>Azevedo, P.R.M.</au><au>Fernandes, J.V.</au><au>Andrade, V.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil</atitle><jtitle>Letters in applied microbiology</jtitle><addtitle>Lett Appl Microbiol</addtitle><date>2018-09</date><risdate>2018</risdate><volume>67</volume><issue>3</issue><spage>285</spage><epage>291</epage><pages>285-291</pages><issn>0266-8254</issn><eissn>1472-765X</eissn><abstract>Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vulva and vagina caused by different yeasts of the genus Candida which is responsible for infection in pregnant patients who attended Maternidade Escola Januário Cicco, Rio Grande do Norte, Brazil. From 41 samples, 19 yeasts were identified phenotypically as Candida albicans and one as Candida glabrata which is reported as the non‐albicans species most frequently isolated from vulvovaginitis. The susceptibility to selected antifungal agents (flucytosine, fluconazole, voriconazole, amphotericin B, caspofungin and micafungin) was determined, and the association between patient‐related signs and symptoms aided the construction of an epidemiological profile. Antifungal susceptibility testing performed by automated method showed that all strains were sensitive to the drugs tested, including the C. glabrata specimen despite its known resistance or dose‐dependent susceptibility to azole derivatives. Regarding patient signs and symptoms, no statistically significant association between these and the establishment of VVC was found. It can be concluded that the laboratorial diagnosis of VVC is necessary prior to the administration of treatment, since only 48·78% of the patients had VVC but for all of them antifungal therapy were prescribed.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.
Significance and Impact of the Study
Vulvovaginal candidiasis (VVC) is a problem that affects a significant number of pregnant women worldwide. This type of fungal infection generates great discomfort due to the symptomatology and difficulties of diagnosis and treatment. In view of the scarcity of data in the State of Rio Grande do Norte, Brazil, regarding studies carried out on fungal populations of the genus Candida associated with VVC in pregnant women, this study considered relevant, the phenotypic and genotypic identification of the species, to estimate the prevalence, to determine their susceptibility to the antifungal and to correlate with signs and symptoms.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29908032</pmid><doi>10.1111/lam.13034</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6923-7143</orcidid><orcidid>https://orcid.org/0000-0002-6220-1321</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0266-8254 |
| ispartof | Letters in applied microbiology, 2018-09, Vol.67 (3), p.285-291 |
| issn | 0266-8254 1472-765X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2056394237 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adolescent Adult Amphotericin B Amphotericin B - pharmacology Antifungal agents Antifungal Agents - pharmacology antifungal susceptibility Brazil - epidemiology Candida Candida - drug effects Candida - genetics Candida - isolation & purification Candida glabrata - isolation & purification Candida species Candidiasis Candidiasis, Vulvovaginal - epidemiology Candidiasis, Vulvovaginal - microbiology Caspofungin Diagnosis Echinocandins - pharmacology Epidemiology Female Fluconazole Fluconazole - pharmacology Flucytosine Fungi Fungicides Humans Infections Lipopeptides - pharmacology Micafungin Microbial Sensitivity Tests Patients Pregnancy Pregnancy Complications - epidemiology Pregnancy Complications - microbiology pregnant women Prevalence Schools - statistics & numerical data Signs and symptoms Species Statistical analysis Statistical methods Test procedures Vagina Voriconazole Vulva vulvovaginal candidiasis Vulvovaginitis Yeasts Young Adult |
| title | Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A36%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20antifungal%20susceptibility%20of%20Candida%20species%20among%20pregnant%20women%20attending%20a%20school%20maternity%20at%20Natal,%20Brazil&rft.jtitle=Letters%20in%20applied%20microbiology&rft.au=Brand%C3%A3o,%20L.D.S.&rft.date=2018-09&rft.volume=67&rft.issue=3&rft.spage=285&rft.epage=291&rft.pages=285-291&rft.issn=0266-8254&rft.eissn=1472-765X&rft_id=info:doi/10.1111/lam.13034&rft_dat=%3Cproquest_cross%3E2084300154%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2084300154&rft_id=info:pmid/29908032&rfr_iscdi=true |